Generic placeholder image

Current Drug Discovery Technologies

Editor-in-Chief

ISSN (Print): 1570-1638
ISSN (Online): 1875-6220

Research Article

In Silico Screening of Some Active Phytochemicals to Identify Promising Inhibitors Against SARS-CoV-2 Targets

Author(s): V. Alagarsamy*, V. Raja Solomon, S. Murugesan, P. Shyam Sundar, MD. Muzaffar-Ur-Rehman, A. Chandu, A. Dharshini Aishwarya, B. Narendhar, M.T. Sulthana and V. Ravikumar

Volume 21, Issue 3, 2024

Published on: 09 October, 2023

Article ID: e091023221906 Pages: 17

DOI: 10.2174/0115701638243222230920051050

Price: $65

Abstract

Background: There are very few small-molecule drug candidates developed against SARS-CoV-2 that have been revealed since the epidemic began in November 2019. The typical medicinal chemistry discovery approach requires more than a decade of the year of painstaking research and development and a significant financial guarantee, which is not feasible in the challenge of the current epidemic.

Objective: This current study proposes to find and identify the most effective and promising phytomolecules against SARS-CoV-2 in six essential proteins (3CL protease, Main protease, Papain- Like protease, N-protein RNA binding domain, RNA-dependent RNA polymerase, and Spike receptor binding domain target through in silico screening of 63 phytomolecules from six different Ayurveda medicinal plants.

Methods: The phytomolecules and SARS-CoV-2 proteins were taken from public domain databases such as PubChem and RCSB Protein Data Bank. For in silico screening, the molecular interactions, binding energy, and ADMET properties were investigated.

Results: The structure-based molecular docking reveals some molecules' greater affinity towards the target than the co-crystal ligand. Our results show that tannic acid, cyanidin-3-rutinoside, zeaxanthin, and carbolactone are phytomolecules capable of inhibiting SARS-CoV-2 target proteins in the least energy conformations. Tannic acid had the least binding energy of -8.8 kcal/mol, which is better than the binding energy of its corresponding co-crystal ligand (-7.5 kcal/mol) against 3 CL protease. Also, it has shown the least binding energy of -9.9 kcal/mol with a more significant number of conventional hydrogen bond interactions against the RdRp target. Cyanidin-3-rutinoside showed binding energy values of -8.8 and -7.6 kcal/mol against Main protease and Papain-like protease, respectively. Zeaxanthin was the top candidate in the N protein RBD with a binding score of - 8.4 kcal/mol, which is slightly better when compared to a co-crystal ligand (-8.2 kcal/mol). In the spike, carbolactone was the suitable candidate with the binding energy of -7.2 kcal/mol and formed a conventional hydrogen bond and two hydrophobic interactions. The best binding affinity-scored phytomolecules were selected for the MD simulations studies.

Conclusion: The present in silico screening study suggested that active phytomolecules from medicinal plants could inhibit SARS-CoV-2 targets. The elite docked compounds with drug-like properties have a harmless ADMET profile, which may help to develop promising COVID-19 inhibitors.

Graphical Abstract

[1]
Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science 2003; 300(5626): 1763-7.
[http://dx.doi.org/10.1126/science.1085658] [PMID: 12746549]
[2]
Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. Hollingsworth, How will country-based mitigation measures influence the course of the COVID-19 epidemic? The Lancet 2020; 395(10228): 931-4.
[3]
Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 2003; 361(9374): 2045-6.
[http://dx.doi.org/10.1016/S0140-6736(03)13615-X] [PMID: 12814717]
[4]
Gates B. Responding to Covid-19 — A once-in-a-century pandemic? N Engl J Med 2020; 382(18): 1677-9.
[5]
Gupta MK, Vemula S, Donde R, Gouda G, Behera L, Vadde R/. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. J Biomol Struct Dyn 2020; 39(7): 2617-27.
[http://dx.doi.org/10.1080/07391102.2020.1751300]
[6]
Pandey S, Yadav B, Pandey A, et al. Lessons from SARS-CoV-2 pandemic: Evolution, disease dynamics and future. Biology 2020; 9(6): 141.
[http://dx.doi.org/10.3390/biology9060141] [PMID: 32604825]
[7]
Hilgenfeld R. From SARS to MERS: Crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS J 2014; 281(18): 4085-96.
[http://dx.doi.org/10.1111/febs.12936] [PMID: 25039866]
[8]
Hu T. Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure. Virology 2009; 388(2): 324-34.
[9]
Wu A, Peng Y, Huang B, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 2020; 27: 325-8.
[10]
V’kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: Implications for SARS-CoV-2. Nat Rev Microbiol 2021; 19(3): 155-70.
[http://dx.doi.org/10.1038/s41579-020-00468-6] [PMID: 33116300]
[11]
Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov 2020; 19(3): 149-50.
[http://dx.doi.org/10.1038/d41573-020-00016-0] [PMID: 32127666]
[12]
Suwannarach N, Kumla J, Sujarit K, et al. Natural bioactive compounds from fungi as potential candidates for protease inhibitors and immunomodulators to apply for coronaviruses. Molecules 2020; 25(8): 1800.
[http://dx.doi.org/10.3390/molecules25081800]
[13]
Sen D, Debnath P, Debnath B, Bhaumik S, Debnath S. Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study. J Biomol Struct Dyn 2022; 40(2): 941-62.
[http://dx.doi.org/10.1080/07391102.2020.1819883] [PMID: 32948116]
[14]
Hu X, Cai X, Song X, et al. Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor. Future Virol 2020; 15(6): 359-68.
[http://dx.doi.org/10.2217/fvl-2020-0099]
[15]
Ibrahim MAA, Abdelrahman AHM, Hussien TA, et al. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors. Comput Biol Med 2020; 126: 104046.
[http://dx.doi.org/10.1016/j.compbiomed.2020.104046] [PMID: 33065388]
[16]
Ibrahim MAA, Mohamed EAR, Abdelrahman AHM, et al. Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study. J Mol Graph Model 2021; 105: 107904.
[http://dx.doi.org/10.1016/j.jmgm.2021.107904] [PMID: 33798836]
[17]
Petricevich V, Abarca-Vargas R. Allamanda cathartica: A Review of the Phytochemistry, Pharmacology, Toxicology, and Biotechnology. Molecules 2019; 24(7): 1238.
[http://dx.doi.org/10.3390/molecules24071238] [PMID: 30934947]
[18]
Hameed A, Nawaz G, Gulzar T. Chemical composition, antioxidant activities and protein profiling of different parts of Allamanda cathartica. Nat Prod Res 2014; 28(22): 2066-71.
[http://dx.doi.org/10.1080/14786419.2014.923997] [PMID: 24931146]
[19]
Lam SH, Chen JM, Tsai SF, Lee SS. Chemical investigation on the root bark of Bombax malabarica. Fitoterapia 2019; 139: 104376.
[http://dx.doi.org/10.1016/j.fitote.2019.104376] [PMID: 31629048]
[20]
Diab K, El-Shenawy R, Helmy N, El-Toumy S. Polyphenol content, antioxidant, cytotoxic, and genotoxic activities of bombax ceiba flowers in liver cancer cells Huh7. Asian Pac J Cancer Prev 2022; 23(4): 1345-50.
[http://dx.doi.org/10.31557/APJCP.2022.23.4.1345] [PMID: 35485695]
[21]
Asati N, Yadava RN. Antibacterial activity of a triterpenoid saponin from the stems of Caesalpinia pulcherrima Linn. Nat Prod Res 2018; 32(5): 499-507.
[http://dx.doi.org/10.1080/14786419.2017.1317772] [PMID: 28423926]
[22]
de Melo CML, da Cruz FIJ, de Sousa GF, et al. Lignin isolated from Caesalpinia pulcherrima leaves has antioxidant, antifungal and immunostimulatory activities. Int J Biol Macromol 2020; 162: 1725-33.
[http://dx.doi.org/10.1016/j.ijbiomac.2020.08.003] [PMID: 32777417]
[23]
Moqbel SAA, Xu K, Chen Z, et al. Tectorigenin alleviates inflammation, apoptosis, and ossification in rat tendon-derived stem cells via modulating NF-Kappa B and MAPK pathways. Front Cell Dev Biol 2020; 8: 568894.
[http://dx.doi.org/10.3389/fcell.2020.568894] [PMID: 33195199]
[24]
Li C, Liu Y, Lin F, Zheng Y, Huang P. Characterization of the complete chloroplast genome sequences of six Dalbergia species and its comparative analysis in the subfamily of Papilionoideae (Fabaceae). PeerJ 2022; 10: e13570.
[http://dx.doi.org/10.7717/peerj.13570]
[25]
Surana AR, Wagh RD. Phytochemical analysis and antidepressant activity of Ixora coccinea extracts in experimental models of depression in mice. Turk J Pharm Sci 2018; 15(2): 130-5.
[http://dx.doi.org/10.4274/tjps.14622] [PMID: 32454651]
[26]
Ali Adnan MS, Al-Amin MM, Nasir UMM, et al. Analgesic, anti-inflammatory, and antipyretic effects of Ixora coccinea. J Basic Clin Physiol Pharmacol 2014.
[http://dx.doi.org/10.1515/jbcpp-2013-0125]
[27]
Abreu PM, Matthew S, González T, et al. Isolation and identification of antioxidants from Pedilanthus tithymaloides. J Nat Med 2007; 62(1): 67-70.
[http://dx.doi.org/10.1007/s11418-007-0186-z] [PMID: 18404345]
[28]
Vidotti GJ, Zimmermann A, Sarragiotto MH, Nakamura CV, Dias Filho BP. Antimicrobial and phytochemical studies on Pedilanthus tithymaloides. Fitoterapia 2006; 77(1): 43-6.
[http://dx.doi.org/10.1016/j.fitote.2005.08.020] [PMID: 16253438]
[29]
Berman HM, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res 2000; 28(1): 235-42.
[http://dx.doi.org/10.1093/nar/28.1.235] [PMID: 10592235]
[30]
RCSB Protein Data Bank: Powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Research 2021; 49: D437-51.
[31]
Garrett M. AutoDock Version 42 - User Guide. Guide 2010; pp. 1-49.
[http://dx.doi.org/10.1002/jcc.21334]
[32]
Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading J Comput Chem 2009; 31(2): NA.
[http://dx.doi.org/10.1002/jcc.21334] [PMID: 19499576]
[33]
[34]
Nourhan M, Olfat M, Mohamed GS, El Sohaimy S. Inhibition of COVID-19 RNA-dependent RNA polymerase by natural bioactive compounds: Molecular docking analysis. Egypt J Chem 2021; 64(4): 1989-2001.
[http://dx.doi.org/10.21608/ejchem.2021.45739.2947]
[35]
Li D, Luan J, Zhang L. Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors. Biochem Biophys Res Commun 2021; 538: 72-9.
[http://dx.doi.org/10.1016/j.bbrc.2020.11.083] [PMID: 33276953]
[36]
Yadav R, Chaudhary JK, Jain N, et al. Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19. Cells 2021; 10(4): 821.
[http://dx.doi.org/10.3390/cells10040821] [PMID: 33917481]
[37]
Lan J, Ge J, Yu J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 2020; 581(7807): 215-20.
[http://dx.doi.org/10.1038/s41586-020-2180-5] [PMID: 32225176]
[38]
Kang S, Yang M, Hong Z, et al. Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites. Acta Pharm Sin B 2020; 10(7): 1228-38.
[http://dx.doi.org/10.1016/j.apsb.2020.04.009] [PMID: 32363136]
[39]
Client DS, Studio D, Discovery T, Client S. Introduction to the discovery studio visualizer. Available from: http://www.adrianomartinelli.it/Fondamenti/Tutorial_0.pdf
[40]
Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 2009; 30(16): 2785-91.
[http://dx.doi.org/10.1002/jcc.21256] [PMID: 19399780]
[41]
a) Desmond Molecular Dynamics System. New York, NY: D. E. Shaw Research 2020.;
b) Maestro-Desmond Interoperability Tools. New York, NY: Schrödinger 2020.
[42]
Jorgensen WL, Maxwell DS, Tirado-Rives J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 1996; 118(45): 11225-36.
[http://dx.doi.org/10.1021/ja9621760]
[43]
Mark P, Nilsson L. Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. J Phys Chem A 2001; 105(43): 9954-60.
[http://dx.doi.org/10.1021/jp003020w]
[44]
Pires DEV, Blundell TL, Ascher DB. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 2015; 58(9): 4066-72.
[http://dx.doi.org/10.1021/acs.jmedchem.5b00104]
[45]
Kicker E, Tittel G, Schaller T, Pferschy-Wenzig EM, Zatloukal K, Bauer R. SARS-CoV-2 neutralizing activity of polyphenols in a special green tea extract preparation. Phytomedicine 2022; 98: 153970.
[http://dx.doi.org/10.1016/j.phymed.2022.153970] [PMID: 35144138]
[46]
Khalifa I, Zhu W, Mohammed HHH, Dutta K, Li C. Tannins inhibit SARS‐CoV‐2 through binding with catalytic dyad residues of 3CL pro: An in silico approach with 19 structural different hydrolysable tannins. J Food Biochem 2020; 44(10): e13432.
[http://dx.doi.org/10.1111/jfbc.13432] [PMID: 32783247]
[47]
Jing W, Xiaolan C, Yu C, Feng Q, Haifeng Y. Pharmacological effects and mechanisms of tannic acid. Biomed Pharmacother 2022; 154: 113561.
[http://dx.doi.org/10.1016/j.biopha.2022.113561] [PMID: 36029537]
[48]
Das A, Pandita D, Jain GK, et al. Role of phytoconstituents in the management of COVID-19. Chem Biol Interact 2021; 341: 109449.
[http://dx.doi.org/10.1016/j.cbi.2021.109449] [PMID: 33798507]
[49]
Wang SC, Chou IW, Hung MC. Natural tannins as anti-SARS-CoV-2 compounds. Int J Biol Sci 2022; 18(12): 4669-76.
[http://dx.doi.org/10.7150/ijbs.74676] [PMID: 35874955]
[50]
Españo E, Kim J, Lee K, Kim JK. Phytochemicals for the treatment of COVID-19. J Microbiol 2021; 59(11): 959-77.
[http://dx.doi.org/10.1007/s12275-021-1467-z] [PMID: 34724178]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy